MDXG MiMedx Group, Inc.

4.610USD-0.22%Mkt Cap: 672.76M $P/E: 115.25

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company processes the human placental tissues membrane, and umbilical cord and the placental disc utilizing i…

Key Statistics

Company
Market Cap672.76M USD
Enterprise Value554.78M USD
Revenue (TTM)355.17M USD
Gross Profit345.62M USD
Net Income (TTM)48.58M USD
Revenue/Share2.40 USD
Last Price4.610 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees808
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)115.25
P/E (Forward)23.10
PEG2.88
EV/EBITDA27.18
EV/Revenue1.56
P/S1.90
P/B3.12
EPS (TTM)0.04
EPS (Forward)0.20
52W Range
3.03032% of range7.970
52W High7.970 USD
52W Low3.030 USD
Profitability
Gross Margin82.56%
Oper. Margin-28.69%
EBITDA Margin5.75%
Profit Margin11.60%
ROE18.94%
ROA14.18%
Growth
Revenue Growth-34.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF74.00M USD
CapEx (TTM)1.03M USD
FCF Margin11.66%
FCF Yield6.16%
Net Debt-118.63M USD
Net Debt/EBITDA-5.81
Balance Sheet
Debt/Equity0.07
Current Ratio5.33
Quick Ratio4.60
Book Value/Sh1.48 USD
Cash/Share0.93 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split3235:10000
Split DateApr 2, 2008
Analyst Consensus
Rating—
Target (Mean)7.400 USD
Upside (mean)+60.5%
Target Range6.000 USD – 8.000 USD
6.000+60.5% to mean8.000
# Analysts5
Ownership
Shares Out.145.93M
Float114.77M
Insiders2.14%
Institutions77.82%
Short Interest
Short Ratio10.7d
Short % Float9.33%
Short % Out.7.37%
Shares Short10.76M
Short (prev mo.)8.89M
Technical
SMA 504.484 (+2.8%)
SMA 2004.479 (+2.9%)
Beta1.17
S&P 52W Chg16.45%
Avg Vol (30d)1.09M
Avg Vol (10d)1.08M
Technical Indicators
RSI (14)51.6
MACD0.0444
MACD Signal0.0764
MACD Hist.-0.0320
BB Upper4.859 USD
BB Middle4.678 USD
BB Lower4.498 USD
BB Width7.72%
ATR (14)0.1708 USD
Vol Ratio (20d)0.68x